Question and answer session with Dr. Randall Bateman on August 14, 2023, on the ending of the open-label extension trial with gantenerumab.
Author: Kelly
2023 Family Conference – Amsterdam, The Netherlands
Thank you to all the participants in the 2023 Conference in Amsterdam. Our highlight this year …..
Audio Presentation: Open-label extension trial with gantenerumab (Links to an external site)
Audio presentation with Dr. Randall Bateman on April 29, 2023, on the open-label extension trial with gantenerumab.
Webinar: The Primary Prevention Clinical trial Q&A (Links to an external site)
Question and answer session with Dr. Eric McDade on December 21, 2022, on the Primary Prevention Clinical trial.
Slides & Audio Presentation: Gantenerumab (Links to an external site)
Slides and audio presentation from November 19, 2022, on gantenerumab. This recording is password protected.
Webinar: Lecanemab Q&A (Links to an external site)
Question and answer session with Dr. Randall Bateman and Dr. Eric McDade on September 30, 2022, on lecanemab.
Update on the DIAN-TU-001 Trial with E2814 and Investigational Lecanemab (Eisai Co., Ltd)
Response to the 28 September 2022 announcement found on Eisai’s website.
Slides & Audio Presentation (Links to an external site)
Slides and audio presentation from May 14, 2022.
Slides & Audio Presentation
View Slide presentation from Nov 2021. In response, a memo from Dr. Bateman and Dr. McDade seeks to clarify reasons for new eligibility criteria for the Tau NexGen clinical trial.
Slides & Audio Presentation: Aducanumab (Links to an external site)
Slides and audio presentation from June 25, 2021 on approval of aducanumab.